DrugDashboards

Market view

orphenadrine citrate · Powder

13 marketed package NDCs · 7 active manufacturers

Most dispensed: 100 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 100 mg · Tablet, Extended Release · #500 tablet, extended releases/bottle · 30 mg/mL · Injection, Solution · #10 vials/carton / 2 ml in 1 vial · 60 mg/2mL · Injection · #25 boxs/box / 10 vial in 1 box / 2 ml in 1 vial

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

What changed in the last 90 days

Every detected change for orphenadrine citrate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Muscle Relaxant, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Orphenadrine citrate in shortage right now?
No. FDA does not currently list Orphenadrine citrate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Orphenadrine citrate?
24 companies have marketed Orphenadrine citrate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Orphenadrine citrate cost?
The typical pharmacy pays about $0.4586 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.